Clinical manifestations and treatment options in patients with cirrhosis and diabetes mellitus

Digestion

Volumn 87, Issue 2, 2013, Pages 75-84

  Gundling, F ^a   Seidl, H ^a   Strassen, I ^a   Haller, B ^a   Siegmund, T ^a   Umgelter, A ^a   Pehl, C ^a   Schepp, W ^a   Schumm Draeger, P M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cirrhosis; Diabetes mellitus; Glycemic control; Hepatogenous diabetes; Impaired glucose tolerance

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ANTIDIABETIC AGENT; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; MEGLITINIDE; METFORMIN; PIOGLITAZONE; REPAGLINIDE; SULFONYLUREA;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DIET THERAPY; FEMALE; GLYCEMIC CONTROL; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MICROANGIOGRAPHY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC PATIENT; END STAGE LIVER DISEASE; METABOLIC REGULATION; PREVALENCE; TREATMENT INDICATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FIBROSIS; HUMANS; HYPOGLYCEMIC AGENTS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84872076270     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000343458     Document Type: Article

References (28)

1. Naunyn B: Glykosurie und Diabetes durch experimentelle Insulte und Krankheiten der Leber; in Naunyn B (ed): Der Diabetes Mellitus. Vienna, A. Holder, 1898, pp 38-49.
2. Perseghini G, Mazzaferro V, Sereni LP, et al: Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology 2000; 31: 694-703.
3. Shetty A, Wilson S, Kuo P, et al: Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance. Transplantation 2000; 69: 2451-2454.
4. Holstein A, Hinze S, Thiessen E, et al: Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002; 17: 677-681.
5. Petrides AS, DeFronzo RA: Glucose metabolism in cirrhosis: a review with some perspectives for the future. Diabetes Metab Rev 1989; 5: 691-709.
6. Petrides AS, Vogt C, Schulze-Berge D, et al: Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 1994; 19: 616-627.
7. Buzzelli G, Chiarantini E, Cotrozzi G, et al: Estimate of prevalence of glucose intolerance in chronic liver disease. Degree of agreement among some diagnostic criteria. Liver 1988; 8: 354-359.
8. Niederau C, Fischer R, Pürschel A, et al: Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119.
9. Hickman IJ, Macdonald GA: Impact of diabetes on the severity of liver disease. Am J Med 2007; 120: 829-834.
10. Gentile S, Loguercio C, Marmo R, et al: Incidence of altered glucose tolerance in liver cirrhosis. Diabetes Res Clin Pract 1993; 22: 37-44.
11. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, et al: Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009; 15: 280-288.
12. Sigal SH, Stanca CM, Kontorinis N, et al: Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis. Am J Gastroenterol 2006; 101: 1490-1496.
13. Nishida T, Tsuji S, Tsuji M, et al: Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006; 101: 70-75.
14. Garcia-Tsao G: Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol 2005; 42(suppl):S85-S92.
15. El-Serag HB, Tran T, Everhart JE: Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-468.
16. Huo TI, Lui WY, Huang YH, et al: Diabetes mellitus is a risk factor for hepatic decompensation in patients with hepatocellular carcinoma undergoing resection: a longitudinal study. Am J Gastroenterol 2003; 98: 2293-2298.
17. Hassan MM, Hwang LY, Hatten CJ, et al: Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatol 2002; 36: 1206-1213.
18. La Vecchia C, Negri E, Recarli A, et al: Diabetes mellitus and the risk of primary liver cancer. Int J Cancer 1997; 73: 204-207.
19. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34(suppl 1):62-69.
20. Petrides AS: New aspects of the regulation of glucose metabolism in chronic liver diseases. Z Gastroenterol 1993; 31(suppl 5):53-55.
21. Petrides AS: Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis. Z Gastroenterol 1999;(suppl 1):15-21.
22. Gentile S, Guarino G, Romano M, et al: A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol 2005; 3: 184-191.
23. Ha NB, Ha NB, Ahmed A, Ayoub W, Daugherty TJ, Chang ET, Lutchman GA, Garcia G, Cooper AD, Keeffe EB, Nguyen MH: Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case-control study. Cancer Causes Control 2012; 23: 455-462.
24. Lai SW, Chen PC, Liao KF, Muo CH, Lin CC, Sung FC: Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population- based cohort study. Am J Gastroenterol 2012; 107: 46-52.
25. Murphy EJ, Davern TJ, Shakil AO, et al: Troglitazone- induced fulminant hepatic failure. Acute Liver Failure Study Group. Dig Dis Sci 2000; 45: 549-553.
26. Nkontchou G, Cosson E, Aout M, Mahmoudi A, Bourcier V, Charif I, Ganne Carrie N, Grando-Lemaire V, Vicaut E, Trinchet JC, Beaugrand M: Impact of metformin on the prognosis of cirrhosis induced by viral hepatitis C in diabetic patients. J Clin Endocrinol Metab 2011; 96: 2601-2608.
27. Donadon V, Balbi M, Mas MD, Casarin P, Zanette G: Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease. Liver Int 2010; 30: 750-758.
28. Kim MG, Choi WC: Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus. Korean J Hepatol 2006; 12: 524-529.